Literature DB >> 30463866

Longitudinal trends in U.S. shortages of sterile solutions, 2001-17.

Maryann Mazer-Amirshahi1, Erin R Fox2, Mark S Zocchi3, Jesse M Pines4, John N van den Anker5.   

Abstract

PURPOSE: Trends in the shortages of sterile solutions in the United States were evaluated.
METHODS: A retrospective review of shortage data from the University of Utah Drug Information Service (UUDIS) was performed. Shortages of sterile solutions, including saline, dextrose, lactated Ringer's, and sterile water for injection, were identified. We extracted the product name, reason for the shortage, shortage duration, and primary use of the solution, examining trends in shortages over time.
RESULTS: There were 37 sterile solution shortages in the UUDIS data set, 22 of which had been resolved. The mean ± S.D. duration of a resolved shortage was 13.9 ± 9.6 months. The most common category of solution shortage was for saline products (n = 11). Manufacturing delay was the most common reason given for shortages (n = 19). In 2017, 12 new shortages were reported, and 15 solutions remained in shortage by year's end. This was the highest number of shortages at any time during the study period. The longest active shortage was for 5% dextrose/0.45% sodium chloride, which began in October 2007 and has yet to be resolved.
CONCLUSION: There were 37 shortages of sterile solutions from 2001 through 2017. Shortages became more severe after Hurricane Maria damaged manufacturing facilities in Puerto Rico, with 12 new shortages reported in 2017.
Copyright © 2018 by the American Society of Health-System Pharmacists, Inc. All rights reserved.

Entities:  

Keywords:  drug shortages; sterile solutions

Mesh:

Substances:

Year:  2018        PMID: 30463866     DOI: 10.2146/ajhp180203

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  4 in total

1.  Creation of a State Drug Shortage Dashboard in the COVID-19 Pandemic.

Authors:  Kristin Lux; Melinda Jorns; Carrie Vogler
Journal:  Hosp Pharm       Date:  2021-09-24

Review 2.  Collaborative Management Strategies for Drug Shortages in Neurocritical Care.

Authors:  Sarah L Clark; Kimberly Levasseur-Franklin; Mehrnaz Pajoumand; Megan Barra; Michael Armahizer; Deepa V Patel; Katleen Wyatt Chester; Andrea P Tully
Journal:  Neurocrit Care       Date:  2020-02       Impact factor: 3.210

Review 3.  Need for more proactive use of pharmacists in the COVID-19 pandemic following lessons learnt from the Great East Japan Earthquake.

Authors:  Takanao Hashimoto; Toyoaki Sawano; Akihiko Ozaki; Masaharu Tsubokura; Takashi Tsuchiya
Journal:  J Glob Health       Date:  2020-12       Impact factor: 4.413

Review 4.  Perspectives on the Health Effects of Hurricanes: A Review and Challenges.

Authors:  Samantha L Waddell; Dushyantha T Jayaweera; Mehdi Mirsaeidi; John C Beier; Naresh Kumar
Journal:  Int J Environ Res Public Health       Date:  2021-03-09       Impact factor: 4.614

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.